105 related articles for article (PubMed ID: 26263246)
1. Regioselectively controlled synthesis of 3(5)-(trifluoromethyl)pyrazolylbenzenesulfonamides and their effects on a pathological pain model in mice.
Lobo MM; Oliveira SM; Brusco I; Machado P; Timmers LF; de Souza ON; Martins MA; Bonacorso HG; Dos Santos JM; Canova B; da Silva TV; Zanatta N
Eur J Med Chem; 2015 Sep; 102():143-52. PubMed ID: 26263246
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents.
Küçükgüzel ŞG; Coşkun İ; Aydın S; Aktay G; Gürsoy Ş; Çevik Ö; Özakpınar ÖB; Özsavcı D; Şener A; Kaushik-Basu N; Basu A; Talele TT
Molecules; 2013 Mar; 18(3):3595-614. PubMed ID: 23519201
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation and molecular modeling study of 5-trifluoromethyl-Δ²-pyrazoline and isomeric 5/3-trifluoromethylpyrazole derivatives as anti-inflammatory agents.
Aggarwal R; Bansal A; Rozas I; Kelly B; Kaushik P; Kaushik D
Eur J Med Chem; 2013; 70():350-7. PubMed ID: 24177361
[TBL] [Abstract][Full Text] [Related]
4. New celecoxib derivatives as anti-inflammatory agents.
Szabó G; Fischer J; Kis-Varga A; Gyires K
J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors.
Chandna N; Kumar S; Kaushik P; Kaushik D; Roy SK; Gupta GK; Jachak SM; Kapoor JK; Sharma PK
Bioorg Med Chem; 2013 Aug; 21(15):4581-90. PubMed ID: 23769654
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive effect of 3-(4-fluorophenyl)-5-trifluoromethyl-1H-1-tosylpyrazole. A Celecoxib structural analog in models of pathological pain.
Oliveira SM; Silva CR; Wentz AP; Paim GR; Correa MS; Bonacorso HG; Prudente AS; Otuki MF; Ferreira J
Pharmacol Biochem Behav; 2014 Sep; 124():396-404. PubMed ID: 25036287
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents.
Abdel-Aziz HA; Al-Rashood KA; ElTahir KE; Suddek GM
Eur J Med Chem; 2014 Jun; 80():416-22. PubMed ID: 24794773
[TBL] [Abstract][Full Text] [Related]
8. 4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties.
Menozzi G; Merello L; Fossa P; Mosti L; Piana A; Mattioli F
Farmaco; 2003 Sep; 58(9):795-808. PubMed ID: 13679172
[TBL] [Abstract][Full Text] [Related]
9. Functional induction of P-glycoprotein efflux pump by phenyl benzenesulfonamides: Synthesis and biological evaluation of T0901317 analogs.
Padala AK; Wani A; Vishwakarma RA; Kumar A; Bharate SB
Eur J Med Chem; 2016 Oct; 122():744-755. PubMed ID: 27497733
[TBL] [Abstract][Full Text] [Related]
10. Divergent chemical synthesis of prolines bearing fluorinated one-carbon units at the 4-position via nucleophilic 5-endo-trig cyclizations.
Nadano R; Iwai Y; Mori T; Ichikawa J
J Org Chem; 2006 Nov; 71(23):8748-54. PubMed ID: 17081002
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antinociceptive activity of new 2-substituted 4-(trifluoromethyl)-5,6-dihydrobenzo[h]quinazolines.
Bonacorso HG; Rosa WC; Oliveira SM; Brusco I; Pozza CCD; Nogara PA; Wiethan CW; Rodrigues MB; Frizzo CP; Zanatta N
Bioorg Med Chem Lett; 2016 Oct; 26(19):4808-4814. PubMed ID: 27561714
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
Penning TD; Talley JJ; Bertenshaw SR; Carter JS; Collins PW; Docter S; Graneto MJ; Lee LF; Malecha JW; Miyashiro JM; Rogers RS; Rogier DJ; Yu SS; AndersonGD ; Burton EG; Cogburn JN; Gregory SA; Koboldt CM; Perkins WE; Seibert K; Veenhuizen AW; Zhang YY; Isakson PC
J Med Chem; 1997 Apr; 40(9):1347-65. PubMed ID: 9135032
[TBL] [Abstract][Full Text] [Related]
13. Regioselectively Controlled Synthesis of N-Substituted (Trifluoromethyl)pyrimidin-2(1H)-ones.
da Silva AM; da Silva FM; Bonacorso HG; Frizzo CP; Martins MA; Zanatta N
J Org Chem; 2016 May; 81(9):3727-34. PubMed ID: 27070191
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel trifluoromethyl-substituted spiro-[chromeno[4,3-d]pyrimidine-5,1'-cycloalkanes], and evaluation of their analgesic effects in a mouse pain model.
Bonacorso HG; Rosa WC; Oliveira SM; Brusco I; Brum ES; Rodrigues MB; Frizzo CP; Zanatta N
Bioorg Med Chem Lett; 2017 Apr; 27(7):1551-1556. PubMed ID: 28259627
[TBL] [Abstract][Full Text] [Related]
15. A general and regioselective synthesis of 5-trifluoromethyl-pyrazoles.
Foster RS; Jakobi H; Harrity JP
Org Lett; 2012 Sep; 14(18):4858-61. PubMed ID: 22934538
[TBL] [Abstract][Full Text] [Related]
16. Chemical and biological investigation of N-hydroxy-valdecoxib: An active metabolite of valdecoxib.
Erdélyi P; Fodor T; Varga AK; Czugler M; Gere A; Fischer J
Bioorg Med Chem; 2008 May; 16(9):5322-30. PubMed ID: 18353655
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new 1-(4-methane(amino)sulfonylphenyl)-5-(4-substituted-aminomethylphenyl)-3-trifluoromethyl-1H-pyrazoles: a search for novel nitric oxide donor anti-inflammatory agents.
Abdellatif KR; Moawad A; Knaus EE
Bioorg Med Chem Lett; 2014 Nov; 24(21):5015-21. PubMed ID: 25304893
[TBL] [Abstract][Full Text] [Related]
18. Regiospecific synthesis of 4-alkoxy and 4-amino substituted 2-trifluoromethyl pyrroles.
Zanatta N; Schneider JM; Schneider PH; Wouters AD; Bonacorso HG; Martins MA; Wessjohann LA
J Org Chem; 2006 Sep; 71(18):6996-8. PubMed ID: 16930054
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effect of a novel tosylpyrazole compound in mice.
Oliveira SM; Gewehr C; Dalmolin GD; Cechinel CA; Wentz A; Lourega RV; Sehnem RC; Zanatta N; Martins MA; Rubin MA; Bonacorso HG; Ferreira J
Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):122-9. PubMed ID: 19143754
[TBL] [Abstract][Full Text] [Related]
20. Peripheral mu-, kappa- and delta-opioid receptors mediate the hypoalgesic effect of celecoxib in a rat model of thermal hyperalgesia.
Correa JD; Paiva-Lima P; Rezende RM; Dos Reis WG; Ferreira-Alves DL; Bakhle YS; Francischi JN
Life Sci; 2010 Jun; 86(25-26):951-6. PubMed ID: 20451533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
